Heart-Lung Transplantation

1

Review clinical trials related to Heart-Lung Transplantation. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

TORCH-LATAM-003: Regional Advanced-Therapy Pathways for Congenital Heart Disease

TORCH-LATAM-003 is a pragmatic stepped-wedge cluster randomized trial evaluating a regional pathway for children and adults with congenital heart disease and advanced cardiac and/or respiratory failure who may require heart, lung, or heart-lung transplantation, mechanical circulatory or extracorporeal support, or another regulated advanced-therapy pathway. Clusters transition from usual local pathways to TORCH-CATP. The primary outcome is completion of the prespecified multidisciplinary evaluation and documentation of an advanced-pathway decision within 90 days after enrollment. The study also evaluates barriers, authorized pathway or waiting-list activation, longitudinal status, advanced support, definitive therapy, and clinical outcomes. Donor-organ and matching events are captured only where legally authorized and do not replace national allocation systems or transplant-center decisions.

Participants needed: 360
Trial details
Age: 0+Biological sex: AllType: InterventionalSponsor: CardioVision International Tech, S.A.S. de C.V.Updated: Oct 13, 2026
Eligibility criteria

Child or adult of any age with congenital heart disease; enrollment of minors re... [+4]

Absence of congenital heart disease as the underlying condition defining the adv... [+3]